David W. Piotrowski

3.1k citations

65 papers · 1.9k indexed · h-index 24

Molecular Biology top 10%
Organic Chemistry top 2%
Cellular and Molecular Neuroscience top 10%
Endocrinology, Diabetes and Metabolism top 10%
Pharmacology top 10%

Co-authors: Theodor Weber Scott E. Denmark Allyn T. LondreganJun XiaoNicole R. Higdon Roch Ogier Daniel Bertrand Judy A. Lawson
Topics: Chemical Synthesis and Analysis (17 papers)Asymmetric Synthesis and Catalysis (9 papers)Historical Linguistics and Language Studies (7 papers)
Cited by: Organic Chemistry Molecular Biology Pharmaceutical Science
Journals: Journal of the American Chemical Society Angewandte Chemie International Edition Journal of Neuroscience
Partner nations: United States China Italy

In The Last Decade

David W. Piotrowski

63 papers receiving 1.8k citations

Peers

Countries citing papers authored by David W. Piotrowski

Since Specialization

Citations

This map shows the geographic impact of David W. Piotrowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Piotrowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Piotrowski more than expected).

Fields of papers citing papers by David W. Piotrowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Piotrowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Piotrowski. The network helps show where David W. Piotrowski may publish in the future.

Co-authorship network of co-authors of David W. Piotrowski

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Piotrowski. A scholar is included among the top collaborators of David W. Piotrowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Piotrowski. David W. Piotrowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups 2023 ·Bioorganic & Medicinal Chemistry Letters ·Gary E. Aspnes,Steven B. Coffey,(unknown),Anne‐Marie Dechert‐Schmitt,Robert Dullea,Adam S. Kamlet,Chris Limberakis,Allyn T. Londregan,Kim F. McClure,Elnaz Menhaji‐Klotz,David W. Piotrowski,Jana Polívková,Brian Raymer,Roger B. Ruggeri,Christopher T. Salatto,Meihua Tu,Liuqing Wei,(unknown)	1
2	6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor 2023 ·Bioorganic & Medicinal Chemistry Letters ·Gary E. Aspnes,Scott W. Bagley,Steven B. Coffey,Edward L. Conn,John M. Curto,David J. Edmonds,Julien Genovino,David A. Griffith,(unknown),Wenhua Jiao,Chris Limberakis,Alan M. Mathiowetz,David W. Piotrowski,Colin R. Rose,Roger B. Ruggeri,Liuqing Wei	4
3	Route Optimization of the Non-covalent Modulator of Hemoglobin PF-07059013 for the Treatment of Sickle Cell Disease, Part I: From Discovery Synthesis to First Kilogram-Scale Manufacture 2023 ·Organic Process Research & Development ·Aaron F. Baldwin,Shawn Cabral,(unknown),Jeffrey T. Kohrt,Chris Limberakis,(unknown),Javier Magano,Sébastien Monfette,Asaad Nematalla,(unknown),David W. Piotrowski,Jared L. Piper,Jeffrey W. Raggon,Benjamin A. Thuma,Liuqing Wei	2
4	Acylative Dynamic Kinetic Resolution of Secondary Alcohols: Tandem Catalysis by HyperBTM and Bäckvall’s Ruthenium Complex 2021 ·The Journal of Organic Chemistry ·(unknown),(unknown),Omar Ahmad,David W. Piotrowski,Edgars Sūna	11
5	RASS‐Enabled S/P−C and S−N Bond Formation for DEL Synthesis 2020 ·Angewandte Chemie ·Dillon T. Flood,Xue‐Jing Zhang,Xiang Fu,(unknown),Shota Asai,Brittany B. Sanchez,(unknown),Julien C. Vantourout,Paul Richardson,Mark E. Flanagan,David W. Piotrowski,Dominik K. Kölmel,Jinqiao Wan,(unknown),Jason S. Chen,Phil S. Baran,Philip E. Dawson	9
6	RASS‐Enabled S/P−C and S−N Bond Formation for DEL Synthesis 2020 ·Angewandte Chemie International Edition ·Dillon T. Flood,Xue‐Jing Zhang,Xiang Fu,(unknown),Shota Asai,Brittany B. Sanchez,(unknown),Julien C. Vantourout,Paul Richardson,Mark E. Flanagan,David W. Piotrowski,Dominik K. Kölmel,Jinqiao Wan,(unknown),Jason S. Chen,Phil S. Baran,Philip E. Dawson	54
7	Expanding Reactivity in DNA-Encoded Library Synthesis via Reversible Binding of DNA to an Inert Quaternary Ammonium Support 2019 ·Journal of the American Chemical Society ·Dillon T. Flood,Shota Asai,Xue‐Jing Zhang,Jie Wang,(unknown),(unknown),Blythe C. Dillingham,Brittany B. Sanchez,Julien C. Vantourout,Mark E. Flanagan,David W. Piotrowski,Paul Richardson,Samantha A. Green,Ryan A. Shenvi,Jason S. Chen,Phil S. Baran,Philip E. Dawson	130
8	Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9 2018 ·Bioorganic & Medicinal Chemistry Letters ·Allyn T. Londregan,Gary E. Aspnes,Chris Limberakis,Paula M. Loria,Kim F. McClure,Donna N. Petersen,Brian Raymer,Roger B. Ruggeri,Liuqing Wei,(unknown),David W. Piotrowski	10
9	David W. Piotrowski, * Kentaro Futatsugi, Agustin Casimiro-Garcia, Liuqing Wei, Matthew F. Sammons, Michael Herr, Wenhua Jiao, Sophie Y. Lavergne, Steven B. Co ff ey, Stephen W. Wright, Kun Song, Paula M. Loria, Mary Ellen Banker, Donna N. Petersen, and J 2018 ·Journal of Medicinal Chemistry ·David W. Piotrowski,Kentaro Futatsugi,(unknown),(unknown),M. F. Sammons,(unknown),Wenhua Jiao,Sophie Y. Lavergne,(unknown),Stephen W. Wright,Kun Song,(unknown),Mary Ellen Banker,Donna N. Petersen,Jonathan Bauman	3
10	Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain 2017 ·PLoS Biology ·Nathanael G. Lintner,Kim F. McClure,Donna N. Petersen,Allyn T. Londregan,David W. Piotrowski,Liuqing Wei,Jun Xiao,Michael W. Bolt,Paula M. Loria,Bruce A. Maguire,Kieran F. Geoghegan,(unknown),Tim Rolph,Spiros Liras,Jennifer A. Doudna,Robert Dullea,J.H.D. Cate	94
11	Phénoménologie et linguistique : un entrelacs [Phenomenology and Linguistics: An Interlacing] 2016 ·(unknown),David W. Piotrowski,Yves-Marie Visetti	1
12	Expression diacritique et sémiogenèse 2015 ·Yves-Marie Visetti,David W. Piotrowski	1
13	Enantioselective synthesis of 1,2,4-triazolines catalyzed by a cinchona alkaloid-derived organocatalyst 2013 ·Chemical Communications ·Qian Shao,Jiean Chen,Meihua Tu,David W. Piotrowski,Yong Huang	21
14	Metabolism, Excretion, and Pharmacokinetics of ((3,3-Difluoropyrrolidin-1-yl)((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone, a Dipeptidyl Peptidase Inhibitor, in Rat, Dog and Human 2012 ·Drug Metabolism and Disposition ·Raman Sharma,Hao Sun,David W. Piotrowski,Tim F. Ryder,Shawn D. Doran,Haiqing Dai,Chandra Prakash	24
15	1-((3S,4S)-4-Amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes 2011 ·Bioorganic & Medicinal Chemistry Letters ·Kim Andrews,David A. Beebe,John W. Benbow,(unknown),Shawn D. Doran,Hui Yu,Shenping Liu,R. Kirk McPherson,Constantin Neagu,Janice C. Parker,David W. Piotrowski,(unknown),Judith L. Treadway,(unknown),William J. Zembrowski	16
16	Phénoménalité et objectivité linguistiques 2009 ·Honoré Champion eBooks ·David W. Piotrowski	1
17	Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Paul S. Humphries,John W. Benbow,Paul D. Bonin,(unknown),Shawn D. Doran,Richard K. Frisbie,David W. Piotrowski,(unknown),Bruce M. Bechle,Edward L. Conn,Kenneth J. DiRico,Robert M. Oliver,Walter C. Soeller,(unknown),Xiaojing Yang	47
18	(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: A potent, selective, orally active dipeptidyl peptidase IV inhibitor 2009 ·Bioorganic & Medicinal Chemistry Letters ·Mark Ammirati,Kim Andrews,(unknown),(unknown),Dennis E. Danley,Shawn D. Doran,Bernard Hulin,Shenping Liu,R. Kirk McPherson,Stephen Orena,Janice C. Parker,Jana Polívková,Xiayang Qiu,(unknown),Judith L. Treadway,Maria A. VanVolkenburg,(unknown),David W. Piotrowski	33
19	A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor:In VitroandIn VivoCharacterization 2005 ·Journal of Neuroscience ·Raymond S Hurst,Mihály Hajós,M. Raggenbass,Theron M. Wall,Nicole R. Higdon,Judy A. Lawson,(unknown),Mitchell B. Berkenpas,William E. Hoffmann,David W. Piotrowski,Vincent E. Groppi,(unknown),Roch Ogier,Sonia Bertrand,Daniel Bertrand,Stephen P. Arnerić	372
20	Dynamiques et structures en langue 1997 ·CNRS Éditions eBooks ·David W. Piotrowski	3

About David W. Piotrowski

David W. Piotrowski is a scholar working on Linguistics and Language, Organic Chemistry and Philosophy, having authored 65 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (17 papers), Asymmetric Synthesis and Catalysis (9 papers) and Historical Linguistics and Language Studies (7 papers). The work is most often cited by research in Organic Chemistry (865 citations), Molecular Biology (1.0k citations) and Pharmaceutical Science (86 citations). David W. Piotrowski has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Theodor Weber, Scott E. Denmark, Allyn T. Londregan, Jun Xiao, Nicole R. Higdon, Roch Ogier, Daniel Bertrand, Judy A. Lawson, Sonia Bertrand and M. Raggenbass. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact